CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed ...

Romios Proposes Name Change and Share Consolidation, Annual General and Special Meeting Scheduled for January 16, 2026

Romios Gold Resources Inc. (TSXV: RG) (OTCID: RMIOF) (FSE: D4R) ("Romios Gold" or the "Company") is pleased to announce that ...